The question of whether ibogaine products are suitable for the ageing population is becoming a central theme in the global dialogue on neuro-regeneration and cognitive longevity. As individuals in Canada, Australia, and Switzerland navigate the natural decline of neurological resilience, many are looking beyond conventional pharmaceuticals toward ethnobotanical interventions. Ibogaine TA, Ibogaine HCL, and Iboga […]